Allen Lutz
Stock Analyst at Bank of America Securities
(4.78)
# 556
Out of 4,639 analysts
604
Total ratings
67.7%
Success rate
12.6%
Average return
Main Sectors:
Stocks Rated by Allen Lutz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACH Accendra Health | Maintained: Sell | $2.25 → $1.3 | $1.29 | +0.78% | 17 | Aug 11, 2026 | |
| HIMS Hims & Hers Health | Reiterated: Hold | $30 → $32 | $30.97 | +3.33% | 75 | Aug 11, 2026 | |
| DH Definitive Healthcare | Reiterated: Sell | $0.7 | $0.71 | -1.41% | 14 | Aug 11, 2026 | |
| PGNY Progyny | Reiterated: Buy | $31 | $27.98 | +10.79% | 23 | Aug 7, 2026 | |
| DOCS Doximity | Reiterated: Sell | $20 | $25.42 | -21.32% | 45 | Aug 7, 2026 | |
| GRDN Guardian Pharmacy Services | Reiterated: Buy | $47 | $41.50 | +13.25% | 6 | Aug 7, 2026 | |
| COR Cencora | Maintained: Hold | n/a | $332.47 | - | 25 | Aug 6, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,050 | $900.00 | +16.67% | 38 | Aug 6, 2026 | |
| NVST Envista Holdings | Reiterated: Buy | $34 | $28.22 | +20.50% | 23 | Aug 6, 2026 | |
| CVS CVS Health | Reiterated: Buy | $120 | $96.27 | +24.65% | 34 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $37.31 | - | 33 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $88.28 | +7.61% | 23 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $7.12 | +47.47% | 79 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $24.38 | +55.87% | 23 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 | $257.00 | +1.17% | 21 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $105.71 | +18.25% | 56 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $11.60 | +46.55% | 23 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.6 → $1.9 | $3.77 | -49.60% | 30 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.70 | n/a | 11 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 | $5.51 | n/a | 3 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $41 | $0.0001 | n/a | 2 | Aug 10, 2022 |
Accendra Health
Aug 11, 2026
Maintained: Sell
Price Target: $2.25 → $1.3
Current: $1.29
Upside: +0.78%
Hims & Hers Health
Aug 11, 2026
Reiterated: Hold
Price Target: $30 → $32
Current: $30.97
Upside: +3.33%
Definitive Healthcare
Aug 11, 2026
Reiterated: Sell
Price Target: $0.7
Current: $0.71
Upside: -1.41%
Progyny
Aug 7, 2026
Reiterated: Buy
Price Target: $31
Current: $27.98
Upside: +10.79%
Doximity
Aug 7, 2026
Reiterated: Sell
Price Target: $20
Current: $25.42
Upside: -21.32%
Guardian Pharmacy Services
Aug 7, 2026
Reiterated: Buy
Price Target: $47
Current: $41.50
Upside: +13.25%
Cencora
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $332.47
Upside: -
McKesson
Aug 6, 2026
Reiterated: Buy
Price Target: $1,050
Current: $900.00
Upside: +16.67%
Envista Holdings
Aug 6, 2026
Reiterated: Buy
Price Target: $34
Current: $28.22
Upside: +20.50%
CVS Health
Aug 5, 2026
Reiterated: Buy
Price Target: $120
Current: $96.27
Upside: +24.65%
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $37.31
Upside: -
Jul 30, 2026
Maintained: Buy
Price Target: $95
Current: $88.28
Upside: +7.61%
Jul 30, 2026
Reiterated: Buy
Price Target: $11
Current: $7.12
Upside: +47.47%
Jul 30, 2026
Reiterated: Buy
Price Target: $38
Current: $24.38
Upside: +55.87%
Jul 20, 2026
Maintained: Buy
Price Target: $260
Current: $257.00
Upside: +1.17%
Jul 9, 2026
Maintained: Buy
Price Target: $125
Current: $105.71
Upside: +18.25%
Jun 11, 2026
Maintained: Buy
Price Target: $17
Current: $11.60
Upside: +46.55%
Feb 26, 2026
Reiterated: Sell
Price Target: $2.6 → $1.9
Current: $3.77
Upside: -49.60%
Aug 5, 2024
Rated: Hold
Price Target: n/a
Current: $13.70
Upside: n/a
Jun 20, 2023
Maintained: Hold
Price Target: $12
Current: $5.51
Upside: n/a
Aug 10, 2022
Maintained: Hold
Price Target: $50 → $41
Current: $0.0001
Upside: n/a